List of Excipients in API alogliptin benzoate and pioglitazone hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing alogliptin benzoate and pioglitazone hydrochloride
Detailed excipient profiles for alogliptin benzoate and pioglitazone hydrochloride
Excipient focus: ALCOHOL
alogliptin benzoate and pioglitazone hydrochloride drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | alogliptin benzoate and pioglitazone hydrochloride | 45802-238 |
| >Company | >Ingredient | >NDC |
alogliptin benzoate and pioglitazone hydrochloride drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
alogliptin benzoate and pioglitazone hydrochloride drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | alogliptin benzoate and pioglitazone hydrochloride | 45802-238 |
| >Company | >Ingredient | >NDC |
alogliptin benzoate and pioglitazone hydrochloride drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARNAUBA WAX
alogliptin benzoate and pioglitazone hydrochloride drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | alogliptin benzoate and pioglitazone hydrochloride | 45802-238 |
| >Company | >Ingredient | >NDC |
alogliptin benzoate and pioglitazone hydrochloride drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
alogliptin benzoate and pioglitazone hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | alogliptin benzoate and pioglitazone hydrochloride | 45802-238 |
| >Company | >Ingredient | >NDC |
alogliptin benzoate and pioglitazone hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
alogliptin benzoate and pioglitazone hydrochloride drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | alogliptin benzoate and pioglitazone hydrochloride | 45802-238 |
| >Company | >Ingredient | >NDC |
alogliptin benzoate and pioglitazone hydrochloride drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
alogliptin benzoate and pioglitazone hydrochloride drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | alogliptin benzoate and pioglitazone hydrochloride | 45802-238 |
| >Company | >Ingredient | >NDC |
alogliptin benzoate and pioglitazone hydrochloride drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
alogliptin benzoate and pioglitazone hydrochloride drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | alogliptin benzoate and pioglitazone hydrochloride | 45802-238 |
| >Company | >Ingredient | >NDC |
alogliptin benzoate and pioglitazone hydrochloride drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
alogliptin benzoate and pioglitazone hydrochloride drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | alogliptin benzoate and pioglitazone hydrochloride | 45802-238 |
| >Company | >Ingredient | >NDC |
alogliptin benzoate and pioglitazone hydrochloride drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
alogliptin benzoate and pioglitazone hydrochloride drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | alogliptin benzoate and pioglitazone hydrochloride | 45802-238 |
| >Company | >Ingredient | >NDC |
alogliptin benzoate and pioglitazone hydrochloride drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
alogliptin benzoate and pioglitazone hydrochloride drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | alogliptin benzoate and pioglitazone hydrochloride | 45802-238 |
| >Company | >Ingredient | >NDC |
alogliptin benzoate and pioglitazone hydrochloride drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
alogliptin benzoate and pioglitazone hydrochloride drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | alogliptin benzoate and pioglitazone hydrochloride | 45802-238 |
| >Company | >Ingredient | >NDC |
alogliptin benzoate and pioglitazone hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
alogliptin benzoate and pioglitazone hydrochloride drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | alogliptin benzoate and pioglitazone hydrochloride | 45802-238 |
| >Company | >Ingredient | >NDC |
alogliptin benzoate and pioglitazone hydrochloride drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
alogliptin benzoate and pioglitazone hydrochloride drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | alogliptin benzoate and pioglitazone hydrochloride | 45802-238 |
| >Company | >Ingredient | >NDC |
alogliptin benzoate and pioglitazone hydrochloride drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYGLYCERYL-10 OLEATE
alogliptin benzoate and pioglitazone hydrochloride drug variants containing POLYGLYCERYL-10 OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | alogliptin benzoate and pioglitazone hydrochloride | 45802-238 |
| >Company | >Ingredient | >NDC |
alogliptin benzoate and pioglitazone hydrochloride drug variants not containing POLYGLYCERYL-10 OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
alogliptin benzoate and pioglitazone hydrochloride drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | alogliptin benzoate and pioglitazone hydrochloride | 45802-238 |
| >Company | >Ingredient | >NDC |
alogliptin benzoate and pioglitazone hydrochloride drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
alogliptin benzoate and pioglitazone hydrochloride drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | alogliptin benzoate and pioglitazone hydrochloride | 45802-238 |
| >Company | >Ingredient | >NDC |
alogliptin benzoate and pioglitazone hydrochloride drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
alogliptin benzoate and pioglitazone hydrochloride drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | alogliptin benzoate and pioglitazone hydrochloride | 45802-238 |
| >Company | >Ingredient | >NDC |
alogliptin benzoate and pioglitazone hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
